APA (7th ed.) Citation

JA, C., & AH, C. (2023). Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis? JAMA neurology, 80(7), 669. https://doi.org/10.1001/jamaneurol.2023.0467

Chicago Style (17th ed.) Citation

JA, Cohen, and Cross AH. "Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?" JAMA Neurology 80, no. 7 (2023): 669. https://doi.org/10.1001/jamaneurol.2023.0467.

MLA (9th ed.) Citation

JA, Cohen, and Cross AH. "Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?" JAMA Neurology, vol. 80, no. 7, 2023, p. 669, https://doi.org/10.1001/jamaneurol.2023.0467.